Gerald Watts

Winthrop Professor, DSc MB BS Lond., PhD W.Aust., DM S'ton, FRCP, FRACP

  • The University of Western Australia (M570), 35 Stirling Highway,

    6009 Perth

    Australia

  • 21643 Citations
  • 71 h-Index
1994 …2020
If you made any changes in Pure these will be visible here soon.

Research Output 1994 2019

Filter
Article
2019

A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolaemia: the Sino-Roman Study

Stefanutti, C., Pang, J., Di Giacomo, S., Wu, X., Wang, X., Morozzi, C., Watts, G. F. & Lin, J., 12 May 2019, In : Journal of Clinical Lipidology.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Blood Component Removal
LDL Cholesterol
Survival
Lipoproteins
LDL Cholesterol
Monoclonal Antibodies
Cardiovascular Diseases
Guidelines
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2 Citations (Scopus)

Comparative aspects of the care of familial hypercholesterolemia in the “Ten Countries Study”

Pang, J., Chan, D. C., Hu, M., Muir, L. A., Kwok, S., Charng, M. J., Florkowski, C. M., George, P. M., Lin, J., Loi, D. D., Marais, A. D., Nawawi, H. M., Gonzalez-Santos, L. E., Su, T. C., Truong, T. H., Santos, R. D., Soran, H., Tomlinson, B., Yamashita, S., Ademi, Z. & 1 othersWatts, G. F., Apr 2019, In : Journal of Clinical Lipidology. 13, 2, p. 287-300

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Delivery of Health Care
Genetic Testing
Education
Developing Countries
Apolipoprotein B-100
Apoprotein(a)
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipoprotein(a)
Apolipoproteins B

Icosapent ethyl for dyslipidaemia in patients with diabetes and coronary artery disease: Act now to reduce it

Lan, N. S. R., Fegan, P. G., Yeap, B. B., Rankin, J. M. & Watts, G. F., 1 Jul 2019, In : Diabetes, Obesity and Metabolism. 21, 7, p. 1734-1736 3 p.

Research output: Contribution to journalArticle

Dyslipidemias
Coronary Artery Disease
Acute Coronary Syndrome
Cardiovascular Diseases
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Identifying Perceptions and Preferences of the General Public Concerning Universal Screening of Children for Familial Hypercholesterolaemia

Bowman, F. L., Molster, C. M., Lister, K. J., Bauskis, A. T., Garton-Smith, J., Vickery, A. W., Watts, G. F. & Martin, A. C., 22 Jul 2019, In : Public Health Genomics.

Research output: Contribution to journalArticle

Open Access
Hyperlipoproteinemia Type II
Inborn Genetic Diseases
Genomics
Coronary Disease
Immunization
2 Citations (Scopus)

Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy

Warden, B. A., Minnier, J., Watts, G. F., Fazio, S. & Shapiro, M. D., 26 Apr 2019, In : Journal of Clinical Lipidology.

Research output: Contribution to journalArticle

Lipoprotein(a)
Niacin
Group Psychotherapy
Therapeutics
Proprotein Convertase 9

Implementing simple algorithms to improve glucose and lipid management in people with diabetes and acute coronary syndrome

Lan, N. S. R., Fegan, P. G., Rankin, J. M., Bell, D. A., Watts, G. F. & Yeap, B. B., 31 Jul 2019, In : Diabetic Medicine. 9 p.

Research output: Contribution to journalArticle

Acute Coronary Syndrome
Prescriptions
Symporters
Lipids
Blood Glucose
1 Citation (Scopus)
Blood Component Removal
Lipoprotein(a)
Apolipoproteins B
LDL Lipoproteins
Metabolism
1 Citation (Scopus)
Open Access
Apoprotein(a)
Lipoprotein(a)
Protein Isoforms
Cholesterol
Therapeutics
3 Citations (Scopus)

Loneliness in psychotic illness and its association with cardiometabolic disorders

Badcock, J. C., Mackinnon, A., Waterreus, A., Watts, G. F., Castle, D., McGrath, J. J. & Morgan, V. A., Feb 2019, In : Schizophrenia Research. 204, p. 90-95 6 p.

Research output: Contribution to journalArticle

Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia

Pérez de Isla, L., Ray, K. K., Watts, G. F., Santos, R. D., Alonso, R., Muñiz-Grijalvo, O., Diaz-Diaz, J. L., Badimon, L., Catapano, A. L. & Mata, P., 1 Jul 2019, In : Atherosclerosis. 286, p. 40-45 6 p.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Monoclonal Antibodies
LDL Cholesterol
Numbers Needed To Treat
Therapeutics
6 Citations (Scopus)

Statin Toxicity

Ward, N. C., Watts, G. F. & Eckel, R. H., 18 Jan 2019, In : Circulation Research. 124, 2, p. 328-350 23 p.

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Muscles
Primary Prevention
Secondary Prevention
LDL Cholesterol
1 Citation (Scopus)
Interleukin-18
Omega-3 Fatty Acids
Interleukin-12
Chronic Renal Insufficiency
C-Reactive Protein

The relationship between pulse pressure and inflammation with left ventricular diastolic dysfunction in chronic kidney disease patients

Yong, K., Mori, T., Chew, G., Beilin, L. J., Puddey, I., Watts, G., Dogra, G., Boudville, N. & Lim, W., 12 Feb 2019, In : Internal Medicine Journal. 49, 2, p. 240-247

Research output: Contribution to journalArticle

Left Ventricular Dysfunction
Chronic Renal Insufficiency
Interleukin-18
Interleukin-12
Blood Pressure
3 Citations (Scopus)

Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia

Ellis, K. L., Pérez de Isla, L., Alonso, R., Fuentes, F., Watts, G. F. & Mata, P., 12 Mar 2019, In : Journal of the American College of Cardiology. 73, 9, p. 1029-1039 11 p.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Lipoprotein(a)
Cardiovascular Diseases
2018
8 Citations (Scopus)
114 Downloads (Pure)
Open Access
File
Hyperlipoproteinemia Type II
Lipids
Mutation
Early Diagnosis
Xanthomatosis
Blood Platelets
Exercise
Platelet Activation
Brachial Artery
Acute Coronary Syndrome
6 Citations (Scopus)

Association between phenotypic familial hypercholesterolaemia and telomere length in US adults: results from a multi-ethnic survey

Banach, M., Mazidi, M., Mikhailidis, D. P., Toth, P. P., Jozwiak, J., Rysz, J. & Watts, G. F., 21 Oct 2018, In : European Heart Journal. 39, 40, p. 3635-3640 6 p.

Research output: Contribution to journalArticle

Open Access
Hyperlipoproteinemia Type II
Telomere
Confidence Intervals
Nutrition Surveys
Lipids
3 Citations (Scopus)
Open Access
Apolipoprotein B-48
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipoproteins
Triglycerides
Apolipoprotein B-100

Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kinetics

Watts, G. F., Chan, D. C., Somaratne, R., Wasserman, S. M., Scott, R., Marcovina, S. M. & Barrett, P. H. R., 14 Jul 2018, In : European Heart Journal. 39, 27, p. 2577-2585 9 p.

Research output: Contribution to journalArticle

Lipoprotein(a)
Apoprotein(a)
AMG 145
Proprotein Convertase 9
Apolipoproteins B
3 Citations (Scopus)

Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia

Hagger, M. S., Hardcastle, S. J., Hu, M., Kwok, S., Lin, J., Nawawi, H. M., Pang, J., Santos, R. D., Soran, H., Su, T-C., Tomlinson, B. & Watts, G. F., Oct 2018, In : Atherosclerosis. 277, p. 493-501 9 p.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Therapeutics
Cross-Sectional Studies
Cholesterol
Demography
8 Citations (Scopus)
Coronary Care Units
Hyperlipoproteinemia Type II
Lipoprotein(a)
Coronary Artery Disease
Acute Coronary Syndrome
3 Citations (Scopus)
Lipoprotein(a)
LDL Cholesterol
Coronary Artery Disease
Coronary Care Units
Hyperlipoproteinemia Type II
1 Citation (Scopus)

Fenofibrate effects on carotid artery intima-media thickness in adults with type 2 diabetes mellitus: A FIELD substudy

Harmer, J. A., Keech, A. C., Veillard, A. S., Skilton, M. R., Watts, G. F. & Celermajer, D. S., 1 Jul 2018, In : Diabetes Research and Clinical Practice. 141, p. 156-167 12 p.

Research output: Contribution to journalArticle

Fenofibrate
Carotid Intima-Media Thickness
Carotid Arteries
Type 2 Diabetes Mellitus
Dyslipidemias
11 Citations (Scopus)
80 Downloads (Pure)

Health literacy in familial hypercholesterolemia: A cross-national study

Hagger, M. S., Hardcastle, S. J., Hu, M., Kwok, S., Lin, J., Nawawi, H. M., Pang, J., Santos, R. D., Soran, H., Su, T-C., Tomlinson, B. & Watts, G. F., Jun 2018, In : European Journal of Cardiovascular Prevention & Rehabilitation. 25, 9, p. 936-943

Research output: Contribution to journalArticle

Open Access
File
Health Literacy
Hyperlipoproteinemia Type II
China
Malaysia
Hong Kong
2 Citations (Scopus)

Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice

Pang, J., David Marais, A., Blom, D. J., Brice, B. C., Silva, P. R., Jannes, C. E., Pereira, A. C., Hooper, A. J., Ray, K. K., Santos, R. D. & Watts, G. F., Oct 2018, In : Atherosclerosis. 277, p. 470-476 7 p.

Research output: Contribution to journalArticle

South Australia
Hyperlipoproteinemia Type II
South Africa
Brazil
Life Style
3 Citations (Scopus)

Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families

Truong, T. H., Kim, N. T., Nguyen, M. N. T., Pang, J., Hooper, A. J., Watts, G. F. & Do, D. L., Oct 2018, In : Atherosclerosis. 277, p. 392-398 7 p.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Vietnam
Genetic Testing
LDL Receptors
Mutation
1 Citation (Scopus)

Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials

Sahebkar, A., Simental-Mendía, L. E., Pirro, M., Banach, M., Watts, G. F., Sirotri, C., Al-Rasadi, K. & Atkin, S. L., 1 Dec 2018, In : Scientific Reports. 8, 1, 17887.

Research output: Contribution to journalArticle

Open Access
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipoprotein(a)
Meta-Analysis
Randomized Controlled Trials
Placebos
6 Citations (Scopus)

Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions

Penson, P. E., Mancini, G. B. J., Toth, P. P., Martin, S. S., Watts, G. F., Sahebkar, A., Mikhailidis, D. P. & Banach, M., 1 Dec 2018, In : Journal of Cachexia, Sarcopenia and Muscle. 9, 6, p. 1023-1033 11 p.

Research output: Contribution to journalArticle

Open Access
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Nocebo Effect
Muscles
Placebo Effect
Myalgia
2 Citations (Scopus)

Knowledge, awareness and practice regarding familial hypercholesterolaemia among primary care physicians in Malaysia: The importance of professional training

Azraii, A. B., Ramli, A. S., Ismail, Z., Abdul-Razak, S., Mohd-Kasim, N. A., Ali, N., Watts, G. F. & Nawawi, H., 1 Oct 2018, In : Atherosclerosis. 277, p. 508-516 9 p.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Malaysia
Primary Care Physicians
Primary Health Care
Certification
1 Citation (Scopus)
Apoprotein(a)
Lipoprotein(a)
Carotid Stenosis
Kringles
Coronary Artery Disease
16 Citations (Scopus)

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

EAS Familial Hypercholesterolaemia Studies Collaboration, the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Investigators & Pang, J., 1 Oct 2018, In : Atherosclerosis. 277, p. 234-255 22 p.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Registries
Research Personnel
Government Programs
Knowledge Management
5 Citations (Scopus)
Hyperlipoproteinemia Type II
Genetic Testing
LDL Cholesterol
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Costs and Cost Analysis
21 Citations (Scopus)
1 Citation (Scopus)

Rationale and design of a trial to personalize risk assessment in familial coronary artery disease

Marwick, T. H., Whitmore, K., Nicholls, S. J., Stanton, T., Mitchell, G., Tonkin, A., Blizzard, C., Neil, A., Jones, C., Watts, G. F. & CAUGHT-CAD Investigators, 1 May 2018, In : American Heart Journal. 199, p. 22-30 9 p.

Research output: Contribution to journalArticle

Coronary Artery Disease
Calcium
Primary Prevention
Guidelines
Cone-Beam Computed Tomography
14 Citations (Scopus)

Simplified Canadian Definition for Familial Hypercholesterolemia

Ruel, I., Brisson, D., Aljenedil, S., Awan, Z., Baass, A., Bélanger, A., Bergeron, J., Bewick, D., Brophy, J. M., Brunham, L. R., Couture, P., Dufour, R., Francis, G. A., Frohlich, J., Gagné, C., Gaudet, D., Grégoire, J. C., Gupta, M., Hegele, R. A., Mancini, G. B. J. & 6 othersMcCrindle, B. W., Pang, J., Raggi, P., Tu, J. V., Watts, G. F. & Genest, J., 1 Sep 2018, In : Canadian Journal of Cardiology. 34, 9, p. 1210-1214 5 p.

Research output: Contribution to journalArticle

Open Access
Hyperlipoproteinemia Type II
LDL Cholesterol
Cardiovascular Diseases
Lipids
Xanthomatosis
5 Citations (Scopus)
coenzyme Q10
Inflammation Mediators
Leukotrienes
Omega-3 Fatty Acids
Chronic Renal Insufficiency
1 Citation (Scopus)

The impact of non-vitamin K antagonist oral anticoagulants (NOACs) on anticoagulation therapy in rural Australia

Bellinge, J. W., Paul, J. J., Walsh, L. S., Garg, L., Watts, G. F. & Schultz, C., 15 Jan 2018, In : The Medical journal of Australia. 208, 1, p. 18-23 6 p.

Research output: Contribution to journalArticle

Open Access
Anticoagulants
Atrial Flutter
Warfarin
Atrial Fibrillation
Therapeutics

Writing on the wall for precision medicine in the prevention of atherosclerotic cardiovascular disease

Watts, G. F. & Stroes, E. S. G., 1 Dec 2018, In : Current Opinion in Lipidology. 29, 6, p. 433-435 3 p.

Research output: Contribution to journalArticle

2017
9 Citations (Scopus)

An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study"

Pang, J., Hu, M., Lin, J., Miida, T., Nawawi, H. M., Park, J. E., Wu, X., Ramli, A. S., Kim, N. T., Kwok, S., Gonzalez-Santos, L. E., Su, T-C., Truong, T. H., Soran, H., Yamashita, S., Tomlinson, B. & Watts, G. F., 25 Oct 2017, In : BMJ Open. 7, 10, p. e017817

Research output: Contribution to journalArticle

Open Access
Hyperlipoproteinemia Type II
Primary Care Physicians
Physicians
Philippines
Vietnam
9 Citations (Scopus)

A Web-Based Registry for Familial Hypercholesterolaemia

Napier, K. R., Pang, J., Lamont, L., Walker, C. E., Dawkins, H. J., Hunter, A. A., Van Bockxmeer, F., Watts, G. F. & Bellgard, M. I., Jun 2017, In : Heart, Lung and Circulation. 26, 6, p. 635-639 5 p.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Registries
Australasia
Clinical Audit
New Zealand
8 Citations (Scopus)

Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study

Bos, S., Duvekot, M. H. C., ten Kate, G. J. R., Verhoeven, A. J. M., Mulder, M. T., Schinkel, A. F. L., Nieman, K., Watts, G. F., Sijbrands, E. J. G. & Roeters van Lennep, J. E., 1 Jan 2017, In : Atherosclerosis. 256, p. 62-66 5 p.

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hyperlipoproteinemia Type II
Carotid Stenosis
Case-Control Studies
Carotid Artery Diseases
21 Citations (Scopus)

Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of head-to-head randomized controlled trials

Sahebkar, A., Simental-Mendía, L. E., Watts, G. F., Serban, M. C., Banach, M. & Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group, 3 Feb 2017, In : BMC Medicine. 15, 1, 22.

Research output: Contribution to journalArticle

Open Access
Fibric Acids
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipoprotein(a)
Meta-Analysis
Randomized Controlled Trials
23 Citations (Scopus)

Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia

Lázaro, P., Pérez de Isla, L., Watts, G. F., Alonso, R., Norman, R., Muñiz, O., Fuentes, F., Mata, N., López-Miranda, J., González-Juanatey, J. R., Díaz-Díaz, J. L., Blasco, A. J. & Mata, P., 1 Jan 2017, In : Journal of Clinical Lipidology. 11, 1, p. 260–271

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Cost-Benefit Analysis
Quality-Adjusted Life Years
Genetic Testing
Decision Trees
7 Citations (Scopus)
105 Downloads (Pure)

Cytomegalovirus antibody and vascular pathology in renal transplant recipients

Price, P., Lee, S., Affandi, J., Parsons, R., Naylor, L. H., Watts, G. F. & Irish, A., 1 Jan 2017, In : Journal of Medical Virology. 89, 1, p. 177-181 5 p.

Research output: Contribution to journalArticle

Open Access
File
Cytomegalovirus
Blood Vessels
Pathology
Kidney
Antibodies
8 Citations (Scopus)

Depicting new pharmacological strategies for familial hypercholesterolaemia involving lipoprotein (a)

Vuorio, A., Watts, G. F. & Kovanen, P. T., 2017, In : European Heart Journal. 38, 48, p. 3555-3559 7 p.

Research output: Contribution to journalArticle

13 Citations (Scopus)
91 Downloads (Pure)

Design of the familial hypercholesterolaemia australasia network registry: Creating opportunities for greater international collaboration

Bellgard, M. I., Walker, C. E., Napier, K. R., Lamont, L., Hunter, A. A., Render, L., Radochonski, M., Pang, J., Pedrotti, A., Sullivan, D. R., Kostner, K., Bishop, W., George, P. M., O’brien, R. C., Clifton, P. M., Van Bockxmeer, F. M., Nicholls, S. J., Hamilton-Craig, I., Dawkins, H. J. S. & Watts, G. F., 1 Jan 2017, In : Journal of Atherosclerosis and Thrombosis. 24, 10, p. 1075-1084 10 p.

Research output: Contribution to journalArticle

Open Access
File
Australasia
Hyperlipoproteinemia Type II
Registries
Patient treatment
Blueprints
4 Citations (Scopus)

Detecting familial hypercholesterolemia: The Jack and the Beanstalk principle

Martin, A. C., Allen, C., Pang, J. & Watts, G. F., 16 May 2017, In : Journal of Clinical Lipidology. 11, 2, p. 575-578 4 p.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Mothers
Hypercholesterolemia
LDL Cholesterol
Fasting